Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.

European journal of cancer (Oxford, England : 1990) - 1 Dec 2010

Xu Wei, Li Yan, Wang Xueli, Chen Bo, Wang Yan, Liu Shifeng, Xu Jijun, Zhao Weihong, Wu Jianqing

Abstract excerpt

Fibroblast growth factor receptor 4 (FGFR4), belonging to the receptor tyrosine kinase family, is involved in cancer initiation and progression. The FGFR4 Gly388Arg polymorphism in the transmembrane domain of the receptor was shown to contribute to genetic susceptibility to cancer but the results were inconsistent. We performed a meta-analysis using 12 eligible case-control studies with a total of 4892 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to FGFR4 gene
Share to Genetic Markers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Neoplasms

Share to Polymorphism, Genetic

Share to Publication Bias

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Risk Factors

Source

Identifiers

PMID: 20638838
DOI: 10.1016/j.ejca.2010.06.017

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.PMID 20638838Read ↗

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Semantic proximity Read ↗

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.Semantic proximity Read ↗

Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer.Semantic proximity Read ↗

New concept on association of FGFR4 G388R, V10I polymorphisms and risk of cancerSemantic proximity Read ↗

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.Semantic proximity Read ↗

Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development.Semantic proximity Read ↗

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.Semantic proximity Read ↗

Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.Semantic proximity Read ↗

The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma PatientsSemantic proximity Read ↗

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.Semantic proximity Read ↗

The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.